Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05).

[1]  N. Shinohara,et al.  Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. , 2007, European urology.

[2]  C. Dinney,et al.  Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. , 2006, The Journal of urology.

[3]  J. McKiernan,et al.  Novel therapeutics in the treatment of bladder cancer , 2004, Current opinion in urology.

[4]  R. Millikan,et al.  Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. , 2004, The Journal of urology.

[5]  R. Millikan,et al.  Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? , 2003, The Journal of urology.

[6]  V. I. Dronov,et al.  [Radical cystectomy in the treatment of invasive bladder cancer]. , 2003, Voenno-meditsinskii zhurnal.

[7]  V. Reuter,et al.  Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. , 2003, The Journal of urology.

[8]  Terry L. Smith,et al.  Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Gerhard Jakse,et al.  Guidelines on bladder cancer. , 2002, European urology.

[10]  L. Collette,et al.  Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  D. Bajorin,et al.  Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. , 2001, The Journal of urology.

[12]  H. Rübben,et al.  Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial. , 2001, Urology.

[13]  P. Albers,et al.  Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  J. Bacik,et al.  Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Dimopoulos,et al.  Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy. , 1994, The Journal of urology.

[16]  L. Einhorn,et al.  Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  F. Freiha,et al.  Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. , 1993, The Journal of urology.

[18]  C. Logothetis,et al.  A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  N. Geller,et al.  M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. , 1988, The Journal of urology.

[20]  D. Johnson,et al.  Long-term results following thoracotomy for metastatic bladder cancer. , 1982, Urology.